Literature DB >> 22322999

Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.

N K Bakshi, G A Fahle, I Sereti, H Wiley, R B Nussenblatt, H N Sen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22322999      PMCID： PMC3351052          DOI： 10.1038/eye.2012.17

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  8 in total

1.  Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates.

Authors:  S Chou; S Guentzel; K R Michels; R C Miner; W L Drew
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

2.  Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

Authors:  D A Jabs; C Enger; J P Dunn; M Forman
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

3.  Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents.

Authors:  N S Lurain; K D Thompson; E W Holmes; G S Read
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV.

Authors:  Quan V Hoang; David M Simon; Gokul N Kumar; Frederick Oh; Debra A Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-01-22       Impact factor: 3.117

Review 5.  Cytomegalovirus infection in patients with AIDS.

Authors:  W L Drew
Journal:  Clin Infect Dis       Date:  1992-02       Impact factor: 9.079

6.  Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir.

Authors:  E Littler; A D Stuart; M S Chee
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

7.  Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant.

Authors:  Irene C Kuo; Yumi Imai; Carol Shum; Daniel F Martin; Baruch D Kuppermann; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2003-01       Impact factor: 5.258

8.  Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome.

Authors:  Douglas A Jabs; Barbara K Martin; Michelle O Ricks; Michael S Forman
Journal:  J Infect Dis       Date:  2006-05-10       Impact factor: 5.226
  8 in total
  5 in total

1.  Synthesis and Characterization of Ganciclovir Long Chain Lipid Prodrugs.

Authors:  Kishore Cholkar; Hoang M Trinh; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Adv Ophthalmol Vis Syst       Date:  2014-08-27

2.  Reply to Frange and Leruez-Ville, "Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases".

Authors:  Nicholas A Turner; Cameron R Wolfe
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

3.  Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.

Authors:  Pierre Frange; Marianne Leruez-Ville
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 4.  Overcoming pharmacologic sanctuaries.

Authors:  Theodore J Cory; Timothy W Schacker; Mario Stevenson; Courtney V Fletcher
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

5.  Late emergence of A594V and L595W mutations related to ganciclovir resistance in a patient with HCMV retinitis and long-term HIV progression.

Authors:  S N Slavov; F C Vilar; V M D Wagatsuma; R C Santana; A A Machado; B A L da Fonseca; S Kashima; D T Covas
Journal:  Braz J Med Biol Res       Date:  2015-08-04       Impact factor: 2.590
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.